Becton Dickinson & Co (NYSE:BDX) Shareholder Mackenzie Financial Corp Upped Position by $38.92 Million as Price Declined

May 16, 2018 - By Megan Stone

Becton, Dickinson and Company (NYSE:BDX) Corporate LogoBig Money Sentiment increased to 1.55 in Q4 2017. It has change of 0.62, from 2017Q3’s 0.93. The ratio increased due to BDX positioning: 50 sold and 294 reduced. 147 funds acquired holdings and 386 increased holdings. Investors holded 197.53 million in 2017Q3 but now own 215.77 million shares or 9.23% more. Foyston Gordon Payne holds 6,300 shs. Johnson Counsel Incorporated reported 29,184 shs or 0.16% of all its holdings. Manchester Mngmt Ltd Liability accumulated 17,946 shs. Peak Asset Mgmt Limited has invested 3.15% in Becton, Dickinson and Company (NYSE:BDX). Envestnet Asset Mngmt holds 89,372 shs. Swiss Bank has invested 0.26% in Becton, Dickinson and Company (NYSE:BDX). Foothills Asset Management Ltd holds 1.9% of its capital in Becton, Dickinson and Company (NYSE:BDX) for 11,716 shs. Parsons Cap Management Ri holds 7,033 shs or 0.17% of its capital. Granite Inv Ptnrs Ltd Liability holds 32,829 shs. Woodmont Investment Counsel Ltd Liability Corp has 0.2% invested in Becton, Dickinson and Company (NYSE:BDX) for 3,658 shs. Rmb Capital Limited Liability, Illinois-based fund reported 82,450 shs. 23,599 were accumulated by Bradley Foster & Sargent Ct. Private Wealth Prns Ltd Llc owns 1,200 shs or 0.05% of their US capital. Drw Ltd Limited Liability Company holds 3,192 shs. Goelzer Investment Mngmt reported 0.03% of its capital in Becton, Dickinson and Company (NYSE:BDX).

BDX had 5 insider sales and 1 insider buy since February 23, 2018. This’s net activity of $4.78 million. On Tuesday, March 13 1,877 shs were sold by Polen Thomas E Jr, worth $426,079. On Monday, May 7 Melcher David F also bought $112,535 worth of Becton, Dickinson and Company (NYSE:BDX). Gallagher John E sold $1.21M worth of Becton, Dickinson and Company (NYSE:BDX) on Tuesday, February 27. RING TIMOTHY M also sold $38,416 worth of Becton, Dickinson and Company (NYSE:BDX) on Friday, February 23. On Monday, February 26 $910,726 worth of stock was sold by Borzi James W.

According to 2018Q1 SEC regulatory report Mackenzie Financial Corp upped its stake in Becton Dickinson & Co (NYSE:BDX) by 18.75%. Becton Dickinson & Co (NYSE:BDX) declined 1.94% with the market as Mackenzie Financial Corp bought 180,176 shares. In 2018Q1, Mackenzie Financial Corp held 1.14M shares of Becton Dickinson & Co (NYSE:BDX), priced at $247.28 million, up from 960,926 last quarter. $60.09 billion is the Becton Dickinson & Co’s MC. BDX reached $224.87 during the last trading session after $0.12 change.Becton, Dickinson and Company is uptrending after having risen 15.92% since May 17, 2017. BDX has 1.20M volume or 3.28% up from normal. BDX outperformed the S&P 500 by 4.37%.

According to the regulatory report Mackenzie Financial Corp’s stake in Bio Techne Corp (NASDAQ:TECH) was reduced by 340,065 shares to 86,941 shares valued at $13.13M in 2018Q1. It operates about $61.70 billion and $39.23 billion US longs. It decreased Lear Corp (NYSE:LEA) position by 76,189 shares to 210,307 shares, and cut its First Rep Bk San Francisco C (NYSE:FRC) stake.

Mackenzie Financial Corp is a Ontario, Canada-based hedge fund with more than $61.70 billion AUM in March, 2014. This fund invests only a small percentage of its assets in equities and options. Mackenzie Financial Corp is the 80th largest hedge fund in our database. Taken from Mackenzie Financial latest Adv, the fund reported to have 1006 full and part-time employees. Among which 70 performing investment advisory and research functions. The hedge fund had more than 200 clients.

Becton, Dickinson and Company (NYSE:BDX) Ratings Coverage

In total 12 analysts cover Becton Dickinson (NYSE:BDX). “Buy” rating has 9, “Sell” are 0, while 3 are “Hold”. 75% are bullish. 13 are the (NYSE:BDX)’s analyst reports since December 14, 2017 according to StockzIntelligence Inc. On Wednesday, December 20 the firm earned “Buy” rating by Cowen & Co. The company rating was maintained by RBC Capital Markets on Thursday, February 8. The company rating was maintained by Deutsche Bank on Friday, December 29. The company rating was upgraded by Citigroup on Friday, January 5. On Wednesday, February 7 the firm has “Equal-Weight” rating given by Morgan Stanley. On Tuesday, February 6 the stock of Becton, Dickinson and Company (NYSE:BDX) earned “Buy” rating by Jefferies. On Tuesday, February 6 the firm earned “Buy” rating by Piper Jaffray. On Tuesday, April 10 Citigroup upgraded Becton, Dickinson and Company (NYSE:BDX) rating. Citigroup has “Buy” rating and $25100 target.

Becton, Dickinson and Company develops, makes, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide.The firm is worth $60.09 billion. It operates in two divisions, BD Medical and BD Life Sciences.Last it reported negative earnings. The BD Medical segment offers syringes, pen needles, and IV sets for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; and prefillable drug delivery systems.

Becton, Dickinson and Company (NYSE:BDX) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: